Log in or Sign up for Free to view tailored content for your specialty!
Hematology News
AI has ‘promising utility’ to give high-quality, empathetic answers to patient questions
AI could have the ability to answer some patient questions on cancer instead of clinicians, reducing clinician burdens and improving access to care, according to study results published in JAMA Oncology.
AACR report: Despite progress, disparities in cancer incidence, mortality persist
The gap in cancer mortality between Black and white individuals shrunk dramatically during the past 3 decades, according to a new report.
Researchers hope one-time gene therapy ‘amounts to a cure’ for hemophilia B
The FDA’s decision to approve a one-time gene therapy for adults with moderate to severe hemophilia B could have a considerable impact on the treatment landscape, according to a researcher involved in the pivotal trial for the agent.
Log in or Sign up for Free to view tailored content for your specialty!
Commentary: It’s in your DNA
It is almost impossible to pick up a medical journal today without seeing an article or commentary on gene editing.
‘Substantial’ contributions: More than 20% of patients participate in cancer research
More than 20% of patients with cancer participate in some form of clinical study, and that number is considered a “floor” estimate, according to study results published in Journal of Clinical Oncology.
Enzyme replacement therapy curbs bleeding events in congenital blood clotting disorder
Among patients with congenital thrombotic thrombocytopenic purpura, prophylactic therapy with recombinant ADAMTS13 restored normal levels of the enzyme, according to results of a randomized phase 3 study.
FDA approves one-time gene therapy Beqvez for hemophilia B
The FDA approved fidanacogene elaparvovec-dzkt for treatment of adults with moderate to severe hemophilia B.
Many children with sickle cell anemia do not receive recommended preventive care
Many children with sickle cell anemia do not receive guideline-concordant preventive care to reduce their risks for serious infections or stroke, according to research conducted at Children’s Hospital Los Angeles.
Exa-cel a ‘first step’ in gene therapy for sickle cell disease, beta-thalassemia
Exagamglogene autotemcel gave most patients with beta-thalassemia transfusion independence and drastically reduced the number of vaso-occlusive crises in those with sickle cell disease in a pair of phase 3 trials.
Next-generation clot removal system for pulmonary embolism cleared by FDA, launched
Penumbra announced the FDA clearance and launch of its next-generation computer-assisted vacuum thrombectomy system to remove venous thrombus and treat pulmonary emboli.
-
Headline News
AACR report: Despite progress, disparities in cancer incidence, mortality persist
May 15, 20245 min read -
Headline News
Once-weekly basal insulin cuts HbA1c for adults with type 2 diabetes in two phase 3 trials
May 16, 20242 min read -
Headline News
How to do body scan meditation
May 14, 20241 min read
-
Headline News
AACR report: Despite progress, disparities in cancer incidence, mortality persist
May 15, 20245 min read -
Headline News
Once-weekly basal insulin cuts HbA1c for adults with type 2 diabetes in two phase 3 trials
May 16, 20242 min read -
Headline News
How to do body scan meditation
May 14, 20241 min read